Abeona Therapeutics (ABEO) Reports In-Line Q1 EPS

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.54), in-line with the analyst estimate of ($0.54).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Vontier completes sale of Teletrac Navman for $220 million
• Radoff-Jumana Group calls for Genesco CEO to lose board chair role